Jump to content

News articles

Innovation

artificial retina
Biomedical / Innovation / Milestones

Graphene oxide added to the composition of the liquid artificial retina: A further step toward clinical trials


Graphene Flagship partner, the Istituto Italiano di Tecnologia, together with IRCCS Azienda Ospedaliera Metropolitana – Policlinico San Martino Hospital, has demonstrated that graphene oxide—used for the first time in the ophthalmic field—enhances the liquid artificial retina, increasing light sensitivity and recovery of visual function in advanced stages of retinitis pigmentosa. The study, published in Nature Communications, led to the restoration of electrical activity in the visual cortex, bringing this strategy closer to future clinical trials in humans.

By Graphene Flagship / 13 May 2026